Equillium
Nasdaq EQ · La Jolla, CA
Works in Dermatology · GI & liver · Immunology
Equillium is a clinical trial sponsor based in La Jolla, CA, listed as Nasdaq EQ. It has 1 active clinical trial with 70 planned participants, in Dermatology, GI & liver and Immunology. Since 2021 it has completed 1 trial and stopped 2 early.
Trial track record · since 2021
Financials · Nasdaq EQ
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Equillium
Equillium is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 70 planned participants, in Dermatology, GI & liver, Immunology. Since 2021 it has completed 1 trial and stopped 2 early.
Equillium is based in La Jolla, CA and is listed as Nasdaq EQ. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Equillium; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-09.
Approve Suite is not affiliated with Equillium.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.